Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA346170
Max Phase: Preclinical
Molecular Formula: C13H19NO
Molecular Weight: 205.30
Molecule Type: Small molecule
Associated Items:
ID: ALA346170
Max Phase: Preclinical
Molecular Formula: C13H19NO
Molecular Weight: 205.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCNC1CCCc2cc(OC)ccc21
Standard InChI: InChI=1S/C13H19NO/c1-3-14-13-6-4-5-10-9-11(15-2)7-8-12(10)13/h7-9,13-14H,3-6H2,1-2H3
Standard InChI Key: OPXDGBRTYJZRGH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 205.30 | Molecular Weight (Monoisotopic): 205.1467 | AlogP: 2.68 | #Rotatable Bonds: 3 |
Polar Surface Area: 21.26 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.60 | CX LogP: 2.72 | CX LogD: 0.56 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.82 | Np Likeness Score: 0.08 |
1. McFarland JW, Gans DJ.. (1986) On the significance of clusters in the graphical display of structure-activity data., 29 (4): [PMID:3959029] [10.1021/jm00154a014] |
2. McFarland JW, Gans DJ.. (1986) On the significance of clusters in the graphical display of structure-activity data., 29 (4): [PMID:3959029] [10.1021/jm00154a014] |
Source(1):